Cargando…

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?

Detalles Bibliográficos
Autores principales:	Shahini, Endrit, Pesce, Francesco, Argentiero, Antonella, Solimando, Antonio Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189654/ https://www.ncbi.nlm.nih.gov/pubmed/37207235 http://dx.doi.org/10.3389/fimmu.2023.1210147

Ejemplares similares

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2022)

Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting
por: Solimando, Antonio G., et al.
Publicado: (2023)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
por: Jay, Cecilia, et al.
Publicado: (2023)

Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
por: Shahini, Endrit, et al.
Publicado: (2023)

Chronic functional constipation is strongly linked to vitamin D deficiency
por: Panarese, Alba, et al.
Publicado: (2019)

Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
por: Solimando, Antonio G., et al.
Publicado: (2023)

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
por: Passardi, Alessandro, et al.
Publicado: (2023)

Vitamin D status and seroconversion for COVID-19 in UK healthcare workers
por: Faniyi, Aduragbemi A., et al.
Publicado: (2021)

Surveillance strategies for precancerous gastric conditions after Helicobacter pylori eradication: There is still need for a tailored approach
por: Shahini, Endrit, et al.
Publicado: (2021)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence
por: Esposito, Susanna, et al.
Publicado: (2022)

Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: Santos, Isabel Kinney Ferreira De Miranda, et al.
Publicado: (2020)

Case Report: Anti-MOG Antibody Seroconversion Accompanied by Dimethyl Fumarate Treatment
por: Takahashi, Keita, et al.
Publicado: (2021)

Seroconversion stages COVID19 into distinct pathophysiological states
por: Galbraith, Matthew D, et al.
Publicado: (2021)

Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis
por: Shahini, Endrit, et al.
Publicado: (2022)

Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection
por: Abu Shanap, Mayada, et al.
Publicado: (2022)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with Obesity
por: Kara, Zehra, et al.
Publicado: (2022)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
por: Prasad, Narayan, et al.
Publicado: (2022)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures
por: Gonçalves, Juliana, et al.
Publicado: (2020)

SARS-COV-2 INFECTION AND SEROCONVERSION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Ruan, Wenly, et al.
Publicado: (2021)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
por: Wirz, Oliver F., et al.
Publicado: (2021)

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?
por: Esposito, Susanna, et al.
Publicado: (2022)

Corrigendum: Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits
por: Kim, Sung-Hee, et al.
Publicado: (2022)

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
por: Wang, Yi, et al.
Publicado: (2023)

Complete Response of Synchronous Liver Metastasis in a Pancreatic Ductal Adenocarcinoma, When Surgery Could Represent a Therapeutic Option
por: Argentiero, Antonella, et al.
Publicado: (2020)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions
por: Panarese, Alba, et al.
Publicado: (2020)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
por: Szewczyk-Dąbrowska, Alina, et al.
Publicado: (2022)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
por: Föhse, Konstantin, et al.
Publicado: (2023)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
por: Argentiero, Antonella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pj0d5gai48n3iprvmnpbrl74hl